{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T06:08:50.546046+00:00","published_at":"2026-10-17T04:45:37.386881+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1bqyfsgja97y","event_type":"CFO_CHANGED","effective_at":"2026-03-25","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:anastasios-konidaris-amrx","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:b92921a4e1f93535329f898f981f054cd31788b32dadf09123936a5aaeb53810"],"summary":"Anastasios Konidaris executive of Amneal Pharmaceuticals, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3dkbbmxgzfqi","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-25","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:andrew-boyer-amrx","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:a867842706a4a765b4943cf4334c4112936abe95d96a299deb30e32aecd091d5"],"summary":"Andrew Boyer executive of Amneal Pharmaceuticals, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1526eec1xi8fu2","event_type":"CEO_CHANGED","effective_at":"2026-03-25","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:chintu-patel-amrx","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:4fe48daf4590b4a7be3de23e52ed46a8cbb9e1fbf927221f9208ec985b15ba27"],"summary":"Chintu Patel executive of Amneal Pharmaceuticals, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:roa2381y3y464","event_type":"CEO_CHANGED","effective_at":"2026-03-25","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:chirag-patel-amrx","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:eee06e82c1c79db9dc54acb1278089caecf917ed14c07fdd8ffafc1fc4821d00"],"summary":"Chirag Patel executive of Amneal Pharmaceuticals, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1qnc6991ythyid","event_type":"GC_CHANGED","effective_at":"2026-03-25","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:james-m-daly","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:b87f01488764419d0890137f983a9abb30329e551b7384bea26102833dc08d1c"],"summary":"James M. Daly executive of Amneal Pharmaceuticals, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1n1sfrj1a2h82d","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-25","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:nikita-shah-amrx","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:21"],"evidence_ids":["alpha:projection-evidence:document:aac279ea9734423a23d218e6bab221c19be6b35545f7aa2bc814b4f0cc837aba"],"summary":"Nikita Shah executive of Amneal Pharmaceuticals, Inc., effective 2026-03-25.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:175cd4dnx0zip","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:chintu-patel","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"Chintu Patel seat on Amneal Pharmaceuticals, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kfd39cjs1qim","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:chirag-patel","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"Chirag Patel seat on Amneal Pharmaceuticals, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dbum0szrazck","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:john-kiely","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"John Kiely seat on Amneal Pharmaceuticals, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1l9mi82zoe1c6","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:shlomo-yanai","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"Shlomo Yanai seat on Amneal Pharmaceuticals, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kxpvfnqc7dk9","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:gautam-patel","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"Gautam Patel seat on Amneal Pharmaceuticals, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:rzeehm12f8h6g","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:j-kevin-buchi","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"J. Kevin Buchi seat on Amneal Pharmaceuticals, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:w2elhi1wfx178","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:45:37.386881+00:00","subject_ids":["alpha:person:ted-nark","alpha:company:a97e7a17-d602-4936-b763-ae017c794afd"],"caused_claim_ids":["alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48"],"summary":"Ted Nark seat on Amneal Pharmaceuticals, Inc., effective 2018-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:5","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:chintu-patel","object_label":"Chintu Patel","object_source_name_forms":[],"value":"Chintu Patel: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:chintu-patel","name":"Chintu Patel"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:6","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:chirag-patel","object_label":"Chirag Patel","object_source_name_forms":[],"value":"Chirag Patel: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:chirag-patel","name":"Chirag Patel"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:8","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gautam-patel","object_label":"Gautam Patel","object_source_name_forms":[],"value":"Gautam Patel: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gautam-patel","name":"Gautam Patel"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:9","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:j-kevin-buchi","object_label":"J. Kevin Buchi","object_source_name_forms":[],"value":"J. Kevin Buchi: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:j-kevin-buchi","name":"J. Kevin Buchi"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:11","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-kiely","object_label":"John Kiely","object_source_name_forms":[],"value":"John Kiely: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-kiely","name":"John Kiely"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:13","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:shlomo-yanai","object_label":"Shlomo Yanai","object_source_name_forms":[],"value":"Shlomo Yanai: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:shlomo-yanai","name":"Shlomo Yanai"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:14","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ted-nark","object_label":"Ted Nark","object_source_name_forms":[],"value":"Ted Nark: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ted-nark","name":"Ted Nark"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:15","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:anastasios-konidaris-amrx","object_label":"Anastasios Konidaris","object_source_name_forms":[],"value":"Anastasios Konidaris: Executive Vice President, Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:anastasios-konidaris-amrx","name":"Anastasios Konidaris"},"title":"Executive Vice President, Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:b92921a4e1f93535329f898f981f054cd31788b32dadf09123936a5aaeb53810","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:35.098597+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:16","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:andrew-boyer-amrx","object_label":"Andrew Boyer","object_source_name_forms":[],"value":"Andrew Boyer: Executive Vice President, Chief Commercial Officer-Generics","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:andrew-boyer-amrx","name":"Andrew Boyer"},"title":"Executive Vice President, Chief Commercial Officer-Generics","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:a867842706a4a765b4943cf4334c4112936abe95d96a299deb30e32aecd091d5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:34.53895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:17","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:chintu-patel-amrx","object_label":"Chintu Patel","object_source_name_forms":[],"value":"Chintu Patel: Co-Chief Executive Officer, Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:chintu-patel-amrx","name":"Chintu Patel"},"title":"Co-Chief Executive Officer, Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:4fe48daf4590b4a7be3de23e52ed46a8cbb9e1fbf927221f9208ec985b15ba27","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:33.490845+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:18","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:chirag-patel-amrx","object_label":"Chirag Patel","object_source_name_forms":[],"value":"Chirag Patel: Co-Chief Executive Officer and President, Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:chirag-patel-amrx","name":"Chirag Patel"},"title":"Co-Chief Executive Officer and President, Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:eee06e82c1c79db9dc54acb1278089caecf917ed14c07fdd8ffafc1fc4821d00","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:34.006862+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:19","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:james-m-daly","object_label":"James M. Daly","object_source_name_forms":[],"value":"James M. Daly: Executive Vice President, Chief Legal Officer and Corporate Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:james-m-daly","name":"James M. Daly"},"title":"Executive Vice President, Chief Legal Officer and Corporate Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:b87f01488764419d0890137f983a9abb30329e551b7384bea26102833dc08d1c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:35.662273+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:a97e7a17-d602-4936-b763-ae017c794afd:leadership_role:21","subject_id":"alpha:company:a97e7a17-d602-4936-b763-ae017c794afd","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:nikita-shah-amrx","object_label":"Nikita Shah","object_source_name_forms":[],"value":"Nikita Shah: Executive Vice President, Chief Human Resources Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:nikita-shah-amrx","name":"Nikita Shah"},"title":"Executive Vice President, Chief Human Resources Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-25","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-25","valid_to":null,"recorded_at":"2026-10-17T04:45:37.386881+00:00","sources":[{"id":"alpha:projection-evidence:document:aac279ea9734423a23d218e6bab221c19be6b35545f7aa2bc814b4f0cc837aba","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:36.180417+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-25T00:00:00+00:00","effective_from":"2026-03-25","effective_until":null,"observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:029993bcccfb895635e53a3ba54d5f0c746d718ec9a988146accd03cd7392a48","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amneal Pharmaceuticals, Inc. DEF 14A 2026-03-25","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25","retrieved_at":"2026-04-24T16:04:02.574+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b92921a4e1f93535329f898f981f054cd31788b32dadf09123936a5aaeb53810","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:35.098597+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a867842706a4a765b4943cf4334c4112936abe95d96a299deb30e32aecd091d5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:34.53895+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:4fe48daf4590b4a7be3de23e52ed46a8cbb9e1fbf927221f9208ec985b15ba27","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:33.490845+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:eee06e82c1c79db9dc54acb1278089caecf917ed14c07fdd8ffafc1fc4821d00","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:34.006862+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b87f01488764419d0890137f983a9abb30329e551b7384bea26102833dc08d1c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:35.662273+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:aac279ea9734423a23d218e6bab221c19be6b35545f7aa2bc814b4f0cc837aba","identity_scope":"source_document_reference","source_type":"sec_filing","title":"AMRX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000130817926000143/lamrx2026_def14a.htm","source_date":"2026-03-25T00:00:00+00:00","retrieved_at":"2026-05-14T23:24:36.180417+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.839,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.838,"cross_source_agreement":0.75,"temporal_completeness":0.765},"diagnostics":{"published_claims":21,"factual_claims":21,"claims_with_linked_evidence":21,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:37.386881+00:00","observed_at":"2026-10-17T04:45:37.386881+00:00","reviewed_at":"2026-10-17T04:45:37.386881+00:00","verified_at":"2026-10-17T04:45:37.386881+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":21,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/amneal-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/amneal-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}